This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
Adrenal medicinal preparations manufacturing
Analgesic preparations manufacturing
Anesthetic preparations manufacturing
Angiourographic diagnostic preparations manufacturing
Antacid preparations manufacturing
Anthelmintic preparations manufacturing
Antibacterial preparations manufacturing
Antibiotic preparations manufacturing
Antidepressant preparations manufacturing
Antihistamine preparations manufacturing
Antineoplastic preparations manufacturing
Antipyretic preparations manufacturing
Antiseptic preparations manufacturing
Antispasmodic preparations manufacturing
Astringent preparations manufacturing
Barbiturate preparations manufacturing
Barium in-vivo diagnostic substances manufacturing
Belladonna preparations manufacturing
Birth control pills manufacturing
Botanical extract preparations (except in-vitro diagnostics) manufacturing
Cardiac preparations manufacturing
Cathartic preparations manufacturing
Central nervous system stimulant preparations manufacturing
Coagulation in-vivo diagnostic substances manufacturing
Cold remedies manufacturing
Contraceptive preparations manufacturing
Contrast media in-vivo diagnostic substances (e.g., iodine, barium) manufacturing
Cough drops, medicated, manufacturing
Cough medicines manufacturing
Cyclopropane medicinal preparations manufacturing
Dermatological preparations manufacturing
Diagnostic biological preparations (except in-vitro) manufacturing
Digestive system preparations manufacturing
Digitalis medicinal preparations manufacturing
Diuretic preparations manufacturing
Effervescent salts manufacturing
Electrolyte in-vivo diagnostic substances manufacturing
Eye and ear preparations manufacturing
Fever remedy preparations manufacturing
Glandular medicinal preparations manufacturing
Hematology in-vivo diagnostic substances manufacturing
Hormone preparations (except in-vitro diagnostics) manufacturing
Insulin preparations manufacturing
Intravenous (IV) solution preparations manufacturing
In-vivo diagnostic substances manufacturing
Iodinated in-vivo diagnostic substances manufacturing
Laxative preparations manufacturing
Lip balms manufacturing
Metabolite in-vivo diagnostic substances manufacturing
Mouthwashes, medicated, manufacturing
Muscle relaxant preparations manufacturing
Nonprescription drug preparations manufacturing
Nuclear medicine (e.g., radioactive isotopes) preparations manufacturing
Oral contraceptive preparations manufacturing
Patent medicine preparations manufacturing
Penicillin preparations manufacturing
Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing
Pituitary gland preparations manufacturing
Radioactive in-vivo diagnostic substances manufacturing
Sedative preparations manufacturing
Sodium chloride pharmaceutical preparations manufacturing
Sodium salicylate preparations manufacturing
Suppositories manufacturing
Technetium medicinal preparations manufacturing
Thyroid preparations manufacturing
Tincture of iodine preparations manufacturing
Tranquilizer preparations manufacturing
Vermifuge preparations manufacturing
Veterinary medicinal preparations manufacturing
Vitamin preparations manufacturing
Water (i.e., drinking) decontamination or purification tablets manufacturing
Zinc oxide medicinal preparations manufacturing
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Answeres comes easily with Industrius CFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine “what if scenarios and P&L impact of reducing costs or adding revenue.
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.